南方能源(01573.HK)回应艾默生报告混杂不实错误属误导午后复牌
格隆汇8月2日丨南方能源(01573.HK)午间发布公告,就Emerson Analytics质疑公司夸大收入等指控作出反驳及╱或澄清。公司董事确认,彼等于该报告发布前并未被EA联系或接受其采访以核实该报告载列的任何数据或资料。
该报告披露了其作者可能于公司股权及╱或衍生工具中拥有好仓或淡仓,并因此在公司股份价格下跌时可实现巨额收益。董事会强调,公司股东及有意投资者于阅览该报告时应该采取非常谨慎的态度并且将该指控视为其作者获取可能的巨利的途径。该报告混杂不实错误,蓄意误导以及没有根据的揣测,公司认为该报告旨在操控股份价格并损害公司声誉。
公司股份将于8月2日下午1时正起复牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.